Meanwhile, high SLC7A7 expression levels were associated with short disease-free survival in LGG, STAD, UVM, and Prostate adenocarcinoma (PRAD) (Fig. 1E). The gene discussed is SLC7A7; the disease is prostate adenocarcinoma.